SlideShare a Scribd company logo
EMERGING MARKETS IN INDIA
       EMERGING MARKETS IN 
              INDIA
         Ms Surbhi Sharma, ITSMA

            Ms. Surbhi Sharma, ITSMA 
Table of Content
Current Scenario of Indian 
 Biotechnology 

Current Scenario of Indian Medical 
Technology

Opportunities

Looking Ahead
Current Scenario of Indian 
  Biotechnology Sector 
Market Segments
                                  Biotechnology


                                                      Bio‐       Bioinformat
Bio‐pharma       Bio‐services       Bio‐agri
                                                   industrials        ics


This sector      Bio‐services      This           This sector    This sector 
accounts for     is the            segment        accounts to    offers 
majority of      second‐           accounts to    about € 89     several 
biotech’s        largest           about € 307    million.       investment 
industry.  It    contributor       million.                      opportunity
accounts to      to the                                          .  It 
about € 1.3      industry.  It                                   accounts to 
billion.         accounts  to                                    about €
                 about € 419                                     36.7 million.
                 million.
Key Players
•   The leading ten companies (in terms of revenues) accounted for 39 per 
    cent of the total industry revenues in 2008–09.

•   MNCs such as Novo Nordisk and Novozymes feature among the leading 10 
    biotech companies.

•   Of the top 20 companies, 19 of them generated revenues worth € 14.6 
    million in 2008–09.

•   The leading 30 home‐grown companies contributed revenues worth € 0.9 
    billion, accounting for 57 per cent of the total revenues of the industry in 
    2008–09.

•   Serum Institute of India and Biocon are the two leading players in the 
    industry.
Current Scenario of Indian Medical 
           Technology
Market Segments
                              Pharmaceuticals


 Contract research                                      Active pharmaceutical 
and manufacturing              Formulations
                                                          ingredients (APIs)
 services (CRAMS)
India is a fast growing       India’s manufacturing       India is the third‐largest 
custom manufacturing                prowess in            player in the world with 
     and research                 formulations is            500 different APIs. 
     outsourcing               validated by the fact 
  destination with a           that it manufactures 
  growth rate that is          60,000 packs across 
   thrice the global             60 therapy areas. 
     market rate.
Key Players
Company              No of Beds   Presence

Apollo Hospitals     4356         Chennai, Madurai, Hyderabad, Karur, 
Enterprise Ltd                    KarimNagar, Mysore, Visakhapatnam, Bilaspur, 
                                  Aragonda, Kakinada, Bengaluru, Delhi, Noida, 
                                  Kolkata, Ahmedabad
Aravind Eye Hospitals 3537        Theni, Tirunelveli, Coimbatore, Puducherry, 
                                  Madurai, Amethi, Kolkata
CARE Hospitals       1666         Hyderabad, Vijaywada, Nagpur, Raipur, 
                                  Bhubaneshwar, Surat, Pune, Visakhapatnam
Fortis Healthcare    5044         Mumbai, Bengaluru, Kolkata, Mohali, Noida, 
Limited                           Delhi, Amritsar, Raipur, Jaipur, Chennai, Kota
Max Hospitals        800          Delhi and NCR

ManipalGroup of      +7000        Udupi, Bengaluru, Manipal, Attavar, Mangalore, 
Hospitals                         Goa, Tumkur, Vijaywada, Kasargod, 
                                  Visakhapatnam
Opportunities
Opportunities – Biopharma
•   The growth in the biosimilars market is 
    driven by an increasing use of biologics in 
    disease areas such as cancer, auto‐            Segment            Potential
    immune and orphan diseases and cost            Bio‐               € 1.45
    containment.                                   pharmaceuticals 

                                                   Bio‐services       € 0.72
•   Companies in this segment include 
    Reliance Biopharma, Shantha Biotech, 
    Panacea Biotec, Wockhardt, Dr Reddy’s, 
    Biocon, Intas Biopharmaceuticals and 
    Avesthagen.

•   Glenmark and Cipla are targeting new 
    product launches in 2010.
Opportunities —bio‐similars
Increasing use of biologics in disease areas such as cancer, auto‐immune
and orphan diseases, in addition to healthcare cost containment, has 
driven the growth of bio‐similars.

Companies in this space include 
•   Reliance Biopharma 
•   Shantha Biotech 
•   Panacea Biotec 
•   Wockhardt 
•   Dr Reddy’s 
•   Biocon 
•   Intas Biopharmaceuticals and 
•   Avesthagen


Glenmark and Cipla are targeting new product launches in 2010.
Looking Ahead
• India is already being globally recognised as a 
  manufacturer of economical, high‐quality bulk drugs and 
  formulations. 

• With a huge base of talented, skilled and cost‐
  competitive manpower, and a well‐developed scientific 
  infrastructure, India has great potential to become a 
  leading global player in biotechnology.

• According to a report by PricewaterhouseCoopers (PwC) 
  in April 2010, India will join the league of top 10 global 
  pharmaceuticals markets in terms of sales by 2020 with 
  the total value reaching €37.82 billion.
Thank You!
     Thank You!
surbhi@itsmaindia.org
        surbhi@itsmaindia.org

More Related Content

What's hot

Pgprak12 group12 mankind pharma
Pgprak12 group12 mankind pharmaPgprak12 group12 mankind pharma
Pgprak12 group12 mankind pharma
Aniket Harsh
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
Sabarinath Suryaprakash
 
Biocon Company Profile
Biocon Company ProfileBiocon Company Profile
Biocon Company Profile
Akash Deep Sharma
 
Biocon AGM 2012 Presentation July 26, 2012
Biocon AGM 2012 Presentation July 26, 2012Biocon AGM 2012 Presentation July 26, 2012
Biocon AGM 2012 Presentation July 26, 2012
Biocon
 
Business Growth Strategy - Biocon
Business Growth Strategy -  BioconBusiness Growth Strategy -  Biocon
Business Growth Strategy - Biocon
yuvrajgill
 
DIPP Compulsory Licencing M F C 2011o
DIPP  Compulsory  Licencing  M F C 2011oDIPP  Compulsory  Licencing  M F C 2011o
DIPP Compulsory Licencing M F C 2011o
Prabir Chatterjee
 

What's hot (6)

Pgprak12 group12 mankind pharma
Pgprak12 group12 mankind pharmaPgprak12 group12 mankind pharma
Pgprak12 group12 mankind pharma
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
 
Biocon Company Profile
Biocon Company ProfileBiocon Company Profile
Biocon Company Profile
 
Biocon AGM 2012 Presentation July 26, 2012
Biocon AGM 2012 Presentation July 26, 2012Biocon AGM 2012 Presentation July 26, 2012
Biocon AGM 2012 Presentation July 26, 2012
 
Business Growth Strategy - Biocon
Business Growth Strategy -  BioconBusiness Growth Strategy -  Biocon
Business Growth Strategy - Biocon
 
DIPP Compulsory Licencing M F C 2011o
DIPP  Compulsory  Licencing  M F C 2011oDIPP  Compulsory  Licencing  M F C 2011o
DIPP Compulsory Licencing M F C 2011o
 

Viewers also liked

Emerging markets in india by Ashok Boddeda
Emerging markets in india by Ashok BoddedaEmerging markets in india by Ashok Boddeda
Emerging markets in india by Ashok Boddeda
Ashok Boddeda
 
Eider castillo navidad
Eider castillo navidadEider castillo navidad
Eider castillo navidad
11215696
 
Ernest Rudyak At A Glance
Ernest Rudyak At A GlanceErnest Rudyak At A Glance
Ernest Rudyak At A Glance
Ernest Rudyak
 
Lecture 1-introduction to c
Lecture 1-introduction to cLecture 1-introduction to c
Lecture 1-introduction to c
Muktadir Shoaib
 
Ark presentation
Ark presentationArk presentation
Ark presentation
brentcarey
 
LASU 2016/2017 1st Round Batch B Provisional Admission List www.alluniversity...
LASU 2016/2017 1st Round Batch B Provisional Admission List www.alluniversity...LASU 2016/2017 1st Round Batch B Provisional Admission List www.alluniversity...
LASU 2016/2017 1st Round Batch B Provisional Admission List www.alluniversity...
Mbadinuju Chiemeka Valentine B.Sc
 
Mihai Pruna Projects and Experience
Mihai Pruna Projects and Experience Mihai Pruna Projects and Experience
Mihai Pruna Projects and Experience
Mihai Pruna
 
Electromagnetism
ElectromagnetismElectromagnetism
Electromagnetism
Kundan Parmar
 
Biosimilars-emerging market in india
Biosimilars-emerging market in indiaBiosimilars-emerging market in india
Biosimilars-emerging market in india
PRUTHVIRAJ. U
 
Digital pen
Digital penDigital pen
Digital pen
Kundan Parmar
 
INDIA - economy analysis
INDIA - economy analysisINDIA - economy analysis
INDIA - economy analysis
Pallav Tyagi
 
Pham Thai Son CV
Pham Thai Son CVPham Thai Son CV
Pham Thai Son CV
Thai Son Pham
 
Search description
Search descriptionSearch description
Socialmediaplan
SocialmediaplanSocialmediaplan
Socialmediaplan
lweller
 
TCVI S.A.F.E.
TCVI S.A.F.E.TCVI S.A.F.E.
TCVI S.A.F.E.
carolinabutton
 
Cal Timely Reminder Staff
Cal Timely Reminder StaffCal Timely Reminder Staff
Cal Timely Reminder Staff
gueste53409
 
QA в Agile
QA в AgileQA в Agile
QA в Agile
Denis Petelin
 
Mexico City Alternative Spring Break Trip 2008
Mexico City Alternative Spring Break Trip 2008Mexico City Alternative Spring Break Trip 2008
Mexico City Alternative Spring Break Trip 2008
sara bendoraitis
 
Le Meilleur Angle
Le Meilleur AngleLe Meilleur Angle
Le Meilleur Angle
guest3ad225
 

Viewers also liked (20)

Emerging markets in india by Ashok Boddeda
Emerging markets in india by Ashok BoddedaEmerging markets in india by Ashok Boddeda
Emerging markets in india by Ashok Boddeda
 
Eider castillo navidad
Eider castillo navidadEider castillo navidad
Eider castillo navidad
 
Ernest Rudyak At A Glance
Ernest Rudyak At A GlanceErnest Rudyak At A Glance
Ernest Rudyak At A Glance
 
Lecture 1-introduction to c
Lecture 1-introduction to cLecture 1-introduction to c
Lecture 1-introduction to c
 
Ark presentation
Ark presentationArk presentation
Ark presentation
 
LASU 2016/2017 1st Round Batch B Provisional Admission List www.alluniversity...
LASU 2016/2017 1st Round Batch B Provisional Admission List www.alluniversity...LASU 2016/2017 1st Round Batch B Provisional Admission List www.alluniversity...
LASU 2016/2017 1st Round Batch B Provisional Admission List www.alluniversity...
 
page2_assignment#5
page2_assignment#5page2_assignment#5
page2_assignment#5
 
Mihai Pruna Projects and Experience
Mihai Pruna Projects and Experience Mihai Pruna Projects and Experience
Mihai Pruna Projects and Experience
 
Electromagnetism
ElectromagnetismElectromagnetism
Electromagnetism
 
Biosimilars-emerging market in india
Biosimilars-emerging market in indiaBiosimilars-emerging market in india
Biosimilars-emerging market in india
 
Digital pen
Digital penDigital pen
Digital pen
 
INDIA - economy analysis
INDIA - economy analysisINDIA - economy analysis
INDIA - economy analysis
 
Pham Thai Son CV
Pham Thai Son CVPham Thai Son CV
Pham Thai Son CV
 
Search description
Search descriptionSearch description
Search description
 
Socialmediaplan
SocialmediaplanSocialmediaplan
Socialmediaplan
 
TCVI S.A.F.E.
TCVI S.A.F.E.TCVI S.A.F.E.
TCVI S.A.F.E.
 
Cal Timely Reminder Staff
Cal Timely Reminder StaffCal Timely Reminder Staff
Cal Timely Reminder Staff
 
QA в Agile
QA в AgileQA в Agile
QA в Agile
 
Mexico City Alternative Spring Break Trip 2008
Mexico City Alternative Spring Break Trip 2008Mexico City Alternative Spring Break Trip 2008
Mexico City Alternative Spring Break Trip 2008
 
Le Meilleur Angle
Le Meilleur AngleLe Meilleur Angle
Le Meilleur Angle
 

Similar to Emerging markets in India / Surbhi Sharma, Secretary General Interactive Technology Software and Media Association, Índia

Biotech industry
Biotech industry Biotech industry
Biotech industry
Strides Shasun
 
The able decade 2003 2012
The able decade 2003 2012The able decade 2003 2012
The able decade 2003 2012
STEPS Centre
 
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...
Ajjay Kumar Gupta
 
Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011
david_singer
 
Biotech & Pharma Market July 2009
Biotech & Pharma Market July 2009Biotech & Pharma Market July 2009
Biotech & Pharma Market July 2009
smnapoleon
 
The Business Of Biotech - Opportunities For Indian Biosimilars : Kapil Khande...
The Business Of Biotech - Opportunities For Indian Biosimilars : Kapil Khande...The Business Of Biotech - Opportunities For Indian Biosimilars : Kapil Khande...
The Business Of Biotech - Opportunities For Indian Biosimilars : Kapil Khande...
Kapil Khandelwal (KK)
 
Medical Equipments
Medical EquipmentsMedical Equipments
Medical Equipments
Dushmanta Pradhan
 
Development of Biopharmaceuticals Industry in India
Development of Biopharmaceuticals Industry in IndiaDevelopment of Biopharmaceuticals Industry in India
Development of Biopharmaceuticals Industry in India
Bhaswat Chakraborty
 
Presentation made by Aagami during Illinois Science and Technology Park Event
Presentation made by Aagami during Illinois Science and Technology Park EventPresentation made by Aagami during Illinois Science and Technology Park Event
Presentation made by Aagami during Illinois Science and Technology Park Event
Aagami, Inc.
 
Phamaceutical sector in india
Phamaceutical sector in indiaPhamaceutical sector in india
Phamaceutical sector in india
Dipankar Biswas
 
India Folder
India FolderIndia Folder
India Folder
dipal_r
 
Indian pharma outlook
Indian pharma outlookIndian pharma outlook
Indian pharma outlook
Akshay Bawa
 
Research Project on Factors affecting Employees Satisfaction
  Research Project on Factors affecting Employees Satisfaction   Research Project on Factors affecting Employees Satisfaction
Research Project on Factors affecting Employees Satisfaction
Kushagra Purohit
 
Api china-2013
Api china-2013Api china-2013
Api china-2013
Arvindkumar S
 
Indian pharma outlook
Indian pharma outlookIndian pharma outlook
Indian pharma outlook
jatin125
 
India Animal Health Market PPT: Demand, Trends and Business Opportunities 202...
India Animal Health Market PPT: Demand, Trends and Business Opportunities 202...India Animal Health Market PPT: Demand, Trends and Business Opportunities 202...
India Animal Health Market PPT: Demand, Trends and Business Opportunities 202...
IMARC Group
 
Pharmaceutical industry in india
Pharmaceutical industry in indiaPharmaceutical industry in india
Pharmaceutical industry in india
Sahil Khanna
 
winter project
winter projectwinter project
winter project
Rishabh Sharma
 
Industry analysis
Industry analysisIndustry analysis
Industry analysis
Kanchuki Sarma
 
Clinical Research In India
Clinical Research In IndiaClinical Research In India
Clinical Research In India
Surya Chitra,PhD MBA
 

Similar to Emerging markets in India / Surbhi Sharma, Secretary General Interactive Technology Software and Media Association, Índia (20)

Biotech industry
Biotech industry Biotech industry
Biotech industry
 
The able decade 2003 2012
The able decade 2003 2012The able decade 2003 2012
The able decade 2003 2012
 
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...
 
Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011
 
Biotech & Pharma Market July 2009
Biotech & Pharma Market July 2009Biotech & Pharma Market July 2009
Biotech & Pharma Market July 2009
 
The Business Of Biotech - Opportunities For Indian Biosimilars : Kapil Khande...
The Business Of Biotech - Opportunities For Indian Biosimilars : Kapil Khande...The Business Of Biotech - Opportunities For Indian Biosimilars : Kapil Khande...
The Business Of Biotech - Opportunities For Indian Biosimilars : Kapil Khande...
 
Medical Equipments
Medical EquipmentsMedical Equipments
Medical Equipments
 
Development of Biopharmaceuticals Industry in India
Development of Biopharmaceuticals Industry in IndiaDevelopment of Biopharmaceuticals Industry in India
Development of Biopharmaceuticals Industry in India
 
Presentation made by Aagami during Illinois Science and Technology Park Event
Presentation made by Aagami during Illinois Science and Technology Park EventPresentation made by Aagami during Illinois Science and Technology Park Event
Presentation made by Aagami during Illinois Science and Technology Park Event
 
Phamaceutical sector in india
Phamaceutical sector in indiaPhamaceutical sector in india
Phamaceutical sector in india
 
India Folder
India FolderIndia Folder
India Folder
 
Indian pharma outlook
Indian pharma outlookIndian pharma outlook
Indian pharma outlook
 
Research Project on Factors affecting Employees Satisfaction
  Research Project on Factors affecting Employees Satisfaction   Research Project on Factors affecting Employees Satisfaction
Research Project on Factors affecting Employees Satisfaction
 
Api china-2013
Api china-2013Api china-2013
Api china-2013
 
Indian pharma outlook
Indian pharma outlookIndian pharma outlook
Indian pharma outlook
 
India Animal Health Market PPT: Demand, Trends and Business Opportunities 202...
India Animal Health Market PPT: Demand, Trends and Business Opportunities 202...India Animal Health Market PPT: Demand, Trends and Business Opportunities 202...
India Animal Health Market PPT: Demand, Trends and Business Opportunities 202...
 
Pharmaceutical industry in india
Pharmaceutical industry in indiaPharmaceutical industry in india
Pharmaceutical industry in india
 
winter project
winter projectwinter project
winter project
 
Industry analysis
Industry analysisIndustry analysis
Industry analysis
 
Clinical Research In India
Clinical Research In IndiaClinical Research In India
Clinical Research In India
 

More from Biocat, BioRegion of Catalonia

Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020
Biocat, BioRegion of Catalonia
 
Catalonia BioRegion report 2020
Catalonia BioRegion report 2020Catalonia BioRegion report 2020
Catalonia BioRegion report 2020
Biocat, BioRegion of Catalonia
 
Biocat presentation
Biocat presentationBiocat presentation
Biocat presentation
Biocat, BioRegion of Catalonia
 
2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation
Biocat, BioRegion of Catalonia
 
Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019
Biocat, BioRegion of Catalonia
 
Biocat Report 2017 Presentation
Biocat Report 2017 PresentationBiocat Report 2017 Presentation
Biocat Report 2017 Presentation
Biocat, BioRegion of Catalonia
 
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Biocat, BioRegion of Catalonia
 
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Biocat, BioRegion of Catalonia
 
EIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH BarcelonaEIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH Barcelona
Biocat, BioRegion of Catalonia
 
CIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH BarcelonaCIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH Barcelona
Biocat, BioRegion of Catalonia
 
CRAASH Barcelona Presentation
CRAASH Barcelona PresentationCRAASH Barcelona Presentation
CRAASH Barcelona Presentation
Biocat, BioRegion of Catalonia
 
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Biocat, BioRegion of Catalonia
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Biocat, BioRegion of Catalonia
 
Presentation Moebio 2018
Presentation Moebio 2018Presentation Moebio 2018
Presentation Moebio 2018
Biocat, BioRegion of Catalonia
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
Biocat, BioRegion of Catalonia
 
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
Biocat, BioRegion of Catalonia
 
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
Biocat, BioRegion of Catalonia
 
"A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa..."A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa...
Biocat, BioRegion of Catalonia
 
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Biocat, BioRegion of Catalonia
 
“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL
“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL
“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL
Biocat, BioRegion of Catalonia
 

More from Biocat, BioRegion of Catalonia (20)

Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020
 
Catalonia BioRegion report 2020
Catalonia BioRegion report 2020Catalonia BioRegion report 2020
Catalonia BioRegion report 2020
 
Biocat presentation
Biocat presentationBiocat presentation
Biocat presentation
 
2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation
 
Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019
 
Biocat Report 2017 Presentation
Biocat Report 2017 PresentationBiocat Report 2017 Presentation
Biocat Report 2017 Presentation
 
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
 
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
 
EIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH BarcelonaEIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH Barcelona
 
CIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH BarcelonaCIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH Barcelona
 
CRAASH Barcelona Presentation
CRAASH Barcelona PresentationCRAASH Barcelona Presentation
CRAASH Barcelona Presentation
 
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
 
Presentation Moebio 2018
Presentation Moebio 2018Presentation Moebio 2018
Presentation Moebio 2018
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
 
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
 
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
 
"A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa..."A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa...
 
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
 
“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL
“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL
“Adding Value through Partnerships: the MedCity Experience”, SIMON HOWELL
 

Recently uploaded

Science Around Us Module 2 Matter Around Us
Science Around Us Module 2 Matter Around UsScience Around Us Module 2 Matter Around Us
Science Around Us Module 2 Matter Around Us
PennapaKeavsiri
 
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Stone Art Hub
 
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
ISONIKELtd
 
list of states and organizations .pdf
list of  states  and  organizations .pdflist of  states  and  organizations .pdf
list of states and organizations .pdf
Rbc Rbcua
 
GKohler - Retail Scavenger Hunt Presentation
GKohler - Retail Scavenger Hunt PresentationGKohler - Retail Scavenger Hunt Presentation
GKohler - Retail Scavenger Hunt Presentation
GraceKohler1
 
Dpboss Matka Guessing Satta Matta Matka Kalyan panel Chart Indian Matka Dpbos...
Dpboss Matka Guessing Satta Matta Matka Kalyan panel Chart Indian Matka Dpbos...Dpboss Matka Guessing Satta Matta Matka Kalyan panel Chart Indian Matka Dpbos...
Dpboss Matka Guessing Satta Matta Matka Kalyan panel Chart Indian Matka Dpbos...
➒➌➎➏➑➐➋➑➐➐Dpboss Matka Guessing Satta Matka Kalyan Chart Indian Matka
 
Registered-Establishment-List-in-Uttarakhand-pdf.pdf
Registered-Establishment-List-in-Uttarakhand-pdf.pdfRegistered-Establishment-List-in-Uttarakhand-pdf.pdf
Registered-Establishment-List-in-Uttarakhand-pdf.pdf
dazzjoker
 
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Niswey
 
Pro Tips for Effortless Contract Management
Pro Tips for Effortless Contract ManagementPro Tips for Effortless Contract Management
Pro Tips for Effortless Contract Management
Eternity Paralegal Services
 
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women MagazineEllen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
CIOWomenMagazine
 
Prescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPTPrescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPT
Freelance
 
一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理
一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理
一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理
taqyea
 
State of D2C in India: A Logistics Update
State of D2C in India: A Logistics UpdateState of D2C in India: A Logistics Update
State of D2C in India: A Logistics Update
RedSeer
 
Cover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SUCover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SU
msthrill
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results
 
Digital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital ExcellenceDigital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital Excellence
Operational Excellence Consulting
 
AI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your BusinessAI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your Business
Arijit Dutta
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results
 
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
valvereliz227
 
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
IPLTech Electric
 

Recently uploaded (20)

Science Around Us Module 2 Matter Around Us
Science Around Us Module 2 Matter Around UsScience Around Us Module 2 Matter Around Us
Science Around Us Module 2 Matter Around Us
 
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
 
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
 
list of states and organizations .pdf
list of  states  and  organizations .pdflist of  states  and  organizations .pdf
list of states and organizations .pdf
 
GKohler - Retail Scavenger Hunt Presentation
GKohler - Retail Scavenger Hunt PresentationGKohler - Retail Scavenger Hunt Presentation
GKohler - Retail Scavenger Hunt Presentation
 
Dpboss Matka Guessing Satta Matta Matka Kalyan panel Chart Indian Matka Dpbos...
Dpboss Matka Guessing Satta Matta Matka Kalyan panel Chart Indian Matka Dpbos...Dpboss Matka Guessing Satta Matta Matka Kalyan panel Chart Indian Matka Dpbos...
Dpboss Matka Guessing Satta Matta Matka Kalyan panel Chart Indian Matka Dpbos...
 
Registered-Establishment-List-in-Uttarakhand-pdf.pdf
Registered-Establishment-List-in-Uttarakhand-pdf.pdfRegistered-Establishment-List-in-Uttarakhand-pdf.pdf
Registered-Establishment-List-in-Uttarakhand-pdf.pdf
 
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
 
Pro Tips for Effortless Contract Management
Pro Tips for Effortless Contract ManagementPro Tips for Effortless Contract Management
Pro Tips for Effortless Contract Management
 
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women MagazineEllen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
 
Prescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPTPrescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPT
 
一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理
一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理
一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理
 
State of D2C in India: A Logistics Update
State of D2C in India: A Logistics UpdateState of D2C in India: A Logistics Update
State of D2C in India: A Logistics Update
 
Cover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SUCover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SU
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
 
Digital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital ExcellenceDigital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital Excellence
 
AI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your BusinessAI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your Business
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
 
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
 
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
 

Emerging markets in India / Surbhi Sharma, Secretary General Interactive Technology Software and Media Association, Índia

  • 1. EMERGING MARKETS IN INDIA EMERGING MARKETS IN  INDIA Ms Surbhi Sharma, ITSMA Ms. Surbhi Sharma, ITSMA 
  • 4. Market Segments Biotechnology Bio‐ Bioinformat Bio‐pharma Bio‐services Bio‐agri industrials ics This sector  Bio‐services  This  This sector  This sector  accounts for  is the  segment  accounts to  offers  majority of  second‐ accounts to  about € 89  several  biotech’s  largest  about € 307  million. investment  industry.  It  contributor  million. opportunity accounts to  to the  .  It  about € 1.3  industry.  It  accounts to  billion. accounts  to  about € about € 419  36.7 million. million.
  • 5. Key Players • The leading ten companies (in terms of revenues) accounted for 39 per  cent of the total industry revenues in 2008–09. • MNCs such as Novo Nordisk and Novozymes feature among the leading 10  biotech companies. • Of the top 20 companies, 19 of them generated revenues worth € 14.6  million in 2008–09. • The leading 30 home‐grown companies contributed revenues worth € 0.9  billion, accounting for 57 per cent of the total revenues of the industry in  2008–09. • Serum Institute of India and Biocon are the two leading players in the  industry.
  • 7. Market Segments Pharmaceuticals Contract research  Active pharmaceutical  and manufacturing  Formulations ingredients (APIs) services (CRAMS) India is a fast growing  India’s manufacturing  India is the third‐largest  custom manufacturing  prowess in  player in the world with  and research  formulations is  500 different APIs.  outsourcing  validated by the fact  destination with a  that it manufactures  growth rate that is  60,000 packs across  thrice the global  60 therapy areas.  market rate.
  • 8. Key Players Company No of Beds Presence Apollo Hospitals  4356 Chennai, Madurai, Hyderabad, Karur,  Enterprise Ltd KarimNagar, Mysore, Visakhapatnam, Bilaspur,  Aragonda, Kakinada, Bengaluru, Delhi, Noida,  Kolkata, Ahmedabad Aravind Eye Hospitals 3537 Theni, Tirunelveli, Coimbatore, Puducherry,  Madurai, Amethi, Kolkata CARE Hospitals 1666 Hyderabad, Vijaywada, Nagpur, Raipur,  Bhubaneshwar, Surat, Pune, Visakhapatnam Fortis Healthcare  5044 Mumbai, Bengaluru, Kolkata, Mohali, Noida,  Limited Delhi, Amritsar, Raipur, Jaipur, Chennai, Kota Max Hospitals  800 Delhi and NCR ManipalGroup of  +7000 Udupi, Bengaluru, Manipal, Attavar, Mangalore,  Hospitals Goa, Tumkur, Vijaywada, Kasargod,  Visakhapatnam
  • 10. Opportunities – Biopharma • The growth in the biosimilars market is  driven by an increasing use of biologics in  disease areas such as cancer, auto‐ Segment  Potential immune and orphan diseases and cost  Bio‐ € 1.45 containment. pharmaceuticals  Bio‐services € 0.72 • Companies in this segment include  Reliance Biopharma, Shantha Biotech,  Panacea Biotec, Wockhardt, Dr Reddy’s,  Biocon, Intas Biopharmaceuticals and  Avesthagen. • Glenmark and Cipla are targeting new  product launches in 2010.
  • 11. Opportunities —bio‐similars Increasing use of biologics in disease areas such as cancer, auto‐immune and orphan diseases, in addition to healthcare cost containment, has  driven the growth of bio‐similars. Companies in this space include  • Reliance Biopharma  • Shantha Biotech  • Panacea Biotec  • Wockhardt  • Dr Reddy’s  • Biocon  • Intas Biopharmaceuticals and  • Avesthagen Glenmark and Cipla are targeting new product launches in 2010.
  • 12. Looking Ahead • India is already being globally recognised as a  manufacturer of economical, high‐quality bulk drugs and  formulations.  • With a huge base of talented, skilled and cost‐ competitive manpower, and a well‐developed scientific  infrastructure, India has great potential to become a  leading global player in biotechnology. • According to a report by PricewaterhouseCoopers (PwC)  in April 2010, India will join the league of top 10 global  pharmaceuticals markets in terms of sales by 2020 with  the total value reaching €37.82 billion.
  • 13. Thank You! Thank You! surbhi@itsmaindia.org surbhi@itsmaindia.org